球菌和肝胆病:更新到2023年
Tatyana Kugler1, Gennady Taradin1
1Donetsk National Medical University, Faculty of postgraduate education, Department of Therapy, Donetsk Oblast, Ucrânia.
Arquivos de gastroenterologia
|August 9, 2023
概括
杆菌感染与肝胆道疾病有关. 需要进一步的研究来确认根除H. pylori是否会改善这些情况.
科学领域:
- 胃肠病学和肝病学
- 传染性疾病 传染性疾病
- 在瘤学瘤学.
背景情况:
- 炎症和瘤起源的肝胆道疾病与Helicobacter感染有关.
- 杆菌 (H. pylori) 是已知的胃肠疾病的原因,新出现的证据表明它在胃外疾病中的作用.
- 该细菌已在肝脏,胆道和胆结石组织中检测到,这表明它可能参与肝胆道病原发生.
研究的目的:
- 审查目前关于H. pylori参与肝胆道疾病的发展和进展的证据.
- 讨论Helicobacter spp.的潜在机制. 转移到肝胆系统中.
- 强调需要对H. pylori根除对肝胆道疾病的影响进行组织病理学确认.
主要方法:
- 临床研究和科学数据的文献综述.
- 对Helicobacter spp.提出的机制的分析. 进入肝胆道系统 (转位,上升途径).
- 检查H. pylori感染的系统性影响,包括促炎性细胞因子活性.
主要成果:
- 临床研究表明,Helicobacter感染与炎症/新发性肝胆道疾病之间存在关联.
- 甲状腺菌感染可以通过促炎性细胞因子 (例如TNF-α,干扰素) 和急性阶段蛋白质产生系统性影响.
- 细菌在肝胆组织中的存在表明了潜在的作用,尽管尚未确定.
结论:
- 杆菌在肝脏和胆道疾病中的确定的作用需要进一步研究.
- 组织病理学确认至关重要,以确定H. pylori的根除是否可以预防或改善肝胆道疾病的进展.
- 其他Helicobacter物种在肝胆道疾病中的临床意义仍在讨论中.
相关概念视频
Diseases of the Liver and Gallbladder
631
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
631
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
454
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
454
Gastritis III: Clinical Manifestations and Management
326
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
326
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
157
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
157
Chronic Bowel Disorders: Introduction
485
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
485
Gastritis-II: Pathophysiology
375
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
375


